MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a Drug License concerning a store in Telangana. The suspension, ordered by the Assistant Director, Drug Control Administration in Warangal, is effective for three days. The company estimates a potential revenue loss of Rs 0.60 lacs due to this temporary operational halt, which began on March 28, 2026.
Operational Update on Subsidiary License Suspension
MedPlus Health Services Limited is announcing an update regarding its subsidiary, Optival Health Solutions Private Limited. The subsidiary has been issued a suspension order impacting the operations of one of its retail stores located in the state of Telangana.
Details of Regulatory Action
The details of the action taken by the regulatory authority are as follows:
- Authority: Assistant Director, Drug Control Administration, Warangal, Telangana.
- Action Initiated: Suspension of the Drug License for the store situated at Parkal Main Road, Telangana.
- Duration of Suspension: Three days.
- Date of Order Receipt: The order was officially received on March 28, 2026.
- Legal Basis: The order references Rule 65 of the Drugs and Cosmetics Act, 1940, and the related Rules of 1945.
Impact Assessment
The company has quantified the immediate financial impact resulting from this temporary suspension of operations. The potential financial impact is estimated to be a revenue loss of Rs 0.60 lacs, which the management considers quantifiable to the extent possible.
The management confirms that this operational disruption is not expected to have a material impact on the overall financial health or activities of the listed entity beyond the immediate, quantified loss.
Source: BSE
